Supplementary Table 6. Demographic and Clinical Characteristics of the MSKCC in silico validation cohort Covariate No. % Type of Tumour 126 100 Primary Biochemical Recurrence 32 25 Yes 94 75 No Metastatic Recurrence 14 11 Yes 112 89 No Site of Metastasis 7 6 Bone 2 2 Local 1 1 RP node, Bone 1 1 Bone, Soft Tissue 1 1 RP node, Lung 1 1 Pelvic node 1 1 Lung 112 89 None Age at Diagnosis 57.6(37.3 - 72.78) Median (Min - Max) Pre-operative PSA 5.9(1.1 - 46.4) Median (Min - Max) Pathological 71 56 T1 50 40 T2 5 4 T3 Surgical Margins (SM) 30 24 Positive 96 76 Negative Seminal Vesicle Invasion (SVI) 13 10 Yes 113 90 No Lymph Node Invasion (LNI) 97 77 No 6 5 Yes 23 18 Unknown Race 23 18 Black Non-Hispanic 94 75 White Non-Hispanic 3 2 Hispanic 2 2 Asian 4 3 Unknown Gleason 40 32 <7 72 57 7 14 11 >7 Supplementary Table 7. Demographic and Clinical characteristics of the Independent Resection Validation Cohort.
Supplementary Table 6. Demographic and Clinical Characteristics of the MSKCC in silico validation cohort Covariate No. % Type of Tumour Primary 126 100 Biochemical Recurrence Yes 32 25 No 94 75 Metastatic Recurrence Yes 14 11 No 112 89 Site of Metastasis Bone 7 6 Local 2 2 RP node, Bone 1 1 Bone, Soft Tissue 1 1 RP node, Lung 1 1 Pelvic node 1 1 Lung 1 1 None 112 89 Age at Diagnosis Median (Min - Max) 57.6(37.3 - 72.78) Pre-operative PSA Median (Min - Max) 5.9(1.1 - 46.4) Pathological T1 71 56 T2 50 40 T3 5 4 Surgical Margins (SM) Positive 30 24 Negative 96 76 Seminal Vesicle Invasion (SVI) Yes 13 10 No 113 90 Lymph Node Invasion (LNI) No 97 77 Yes 6 5 Unknown 23 18 Race Black Non-Hispanic 23 18 White Non-Hispanic 94 75 Hispanic 3 2 Asian 2 2 Unknown 4 3 Gleason <7 40 32 7 72 57 >7 14 11 Supplementary Table 7. Demographic and Clinical characteristics of the Independent Resection Validation Cohort.
REF%20EURUROL-D-16-01757%202nd%20Re-submission%20%28MARK-UP%29.docx